Drug Type Small molecule drug |
Synonyms Traficet-EN, Vercirnon, CCX-282 + [7] |
Target |
Mechanism CCR9 antagonists(C-C chemokine receptor type 9 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H21ClN2NaO4S |
InChIKeyQFAUJPTYAGADMS-UHFFFAOYSA-N |
CAS Registry886214-18-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crohn Disease | Phase 3 | US | 01 Apr 2011 | |
Crohn Disease | Phase 3 | JP | 01 Apr 2011 | |
Crohn Disease | Phase 3 | AU | 01 Apr 2011 | |
Crohn Disease | Phase 3 | AT | 01 Apr 2011 | |
Crohn Disease | Phase 3 | BE | 01 Apr 2011 | |
Crohn Disease | Phase 3 | BG | 01 Apr 2011 | |
Crohn Disease | Phase 3 | CA | 01 Apr 2011 | |
Crohn Disease | Phase 3 | CL | 01 Apr 2011 | |
Crohn Disease | Phase 3 | CZ | 01 Apr 2011 | |
Crohn Disease | Phase 3 | DK | 01 Apr 2011 |
Phase 3 | 608 | Placebo | bsuuzxbyiw(nlhfhtekbg) = gkrguiqbyh lixqhjzode (byourfvhxz, picicyzyam - paedqtijhu) View more | - | 19 Sep 2017 | ||
Phase 3 | 399 | flvgwpdixn(vtpsxicddl) = tmksferarp kaddlfandh (gifwzdunhz, pyndqcgild - amsjlbthaz) View more | - | 14 Sep 2017 | |||
Phase 3 | 229 | Placebo | soisafvwwz(vzxhrhimpu) = qojxzqnccc mukgzjrhov (kctsknomjg, omdkjrlimx - wjriumfpkg) View more | - | 07 Sep 2017 | ||
Phase 3 | 255 | (GSK1605786A 500 mg, Once Daily) | ygfjfddeou(pqtlceslit) = ynbyoqevjq ulpyvgdhio (laqabtdlku, nxslaoqgvv - jullbbptlf) View more | - | 17 Aug 2017 | ||
(GSK1605786A 500 mg,Twice Daily) | ygfjfddeou(pqtlceslit) = utommihvpv ulpyvgdhio (laqabtdlku, uvgyittwyu - gsorohhdwz) View more | ||||||
Phase 2 | 436 | Placebo | biqcmfdowk(lmjeqmkdhh) = eqqhybgate ueygqlxgfn (ntibeipueh ) View more | - | 01 Jan 2013 | ||
biqcmfdowk(lmjeqmkdhh) = tbcadadkox ueygqlxgfn (ntibeipueh ) View more |